Maternal Investigational RSV Vaccine Study

Now Enrolling in Covington, Grand Island, Hastings, Norfolk

Now Enrolling

About this research study

Respiratory syncytial virus (RSV) can be life-threatening for newborns. More than a common cold, RSV can lead to severe infections, including pneumonia. In the U.S., RSV is the leading cause of infant hospitalization. Scientists are researching an investigational maternal RSV vaccine.

Velocity is conducting a research study on an investigational maternal RSV vaccine.

Eligible participants...

  • Must be a pregnant woman age 18 to 39 years of age
  • Must NOT have current pregnancy complications or abnormalities
  • Must NOT have a history of prior pregnancy complications or abnormalities
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Covington, Louisiana • Velocity Clinical Research

190 Greenbriar Blvd. Suite 101-102, Covington, LA 70433
Phone: (985) 273-0855

Grand Island, Nebraska • Velocity Clinical Research

711 N. Custer Ave., Suite B, Grand Island, NE 68803
Phone: (308) 365-8900

Norfolk, Nebraska • Velocity Clinical Research

3400 W Norfolk Avenue, Norfolk, NE 68701
Phone: (402) 371-0797
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy